Cargando…
Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer
Local immunotherapy resurfaces in the field of cancer as a potential way to cure localized and metastatic disease with limited toxic effects. We have recently demonstrated that local administration of agonistic CD40 antibodies can cure localized as well as disseminated bladder neoplasms. This approa...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962505/ https://www.ncbi.nlm.nih.gov/pubmed/24701374 http://dx.doi.org/10.4161/onci.27400 |